From: Application of a composite measure of product adherence, protocol compliance, and semen exposure to a phase III microbicide HIV prevention trial
Percent of applicators in the set deemed vaginally inserted
Number of participants (n)
Percent of total participants
0%
12
11.8%
1–79%
7
6.9%
80–100%
82
81.2%
Totals
101
100%